Increased expression of GPR19 leads to a statistically significant decrease in survival, suggesting that high expression of GPR19 could constitute a negative prognostic factor of adrenocortical carcinoma disease progression, however this aspect require further studies. The gene discussed is GPR19; the disease is adrenal cortex carcinoma.